BIOMAT Database Logo BIOMAT Database Logo

A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis. 2010

Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
Florey Neuroscience Institutes, University of Melbourne, Melbourne, Victoria, Australia.

We conducted an association study across the human leukocyte antigen (HLA) complex to identify loci associated with multiple sclerosis (MS). Comparing 1927 SNPs in 1618 MS cases and 3413 controls of European ancestry, we identified seven SNPs that were independently associated with MS conditional on the others (each P ≤ 4 x 10(-6)). All associations were significant in an independent replication cohort of 2212 cases and 2251 controls (P ≤ 0.001) and were highly significant in the combined dataset (P ≤ 6 x 10(-8)). The associated SNPs included proxies for HLA-DRB1*15:01 and HLA-DRB1*03:01, and SNPs in moderate linkage disequilibrium (LD) with HLA-A*02:01, HLA-DRB1*04:01 and HLA-DRB1*13:03. We also found a strong association with rs9277535 in the class II gene HLA-DPB1 (discovery set P = 9 x 10(-9), replication set P = 7 x 10(-4), combined P = 2 x 10(-10)). HLA-DPB1 is located centromeric of the more commonly typed class II genes HLA-DRB1, -DQA1 and -DQB1. It is separated from these genes by a recombination hotspot, and the association is not affected by conditioning on genotypes at DRB1, DQA1 and DQB1. Hence rs9277535 represents an independent MS-susceptibility locus of genome-wide significance. It is correlated with the HLA-DPB1*03:01 allele, which has been implicated previously in MS in smaller studies. Further genotyping in large datasets is required to confirm and resolve this association.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006682 HLA-DP Antigens A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-PL Antigens,HLA-SB Antigens,HLA-DP,HLA-PL,HLA-SB,Antigens, HLA-DP,Antigens, HLA-PL,Antigens, HLA-SB,HLA DP Antigens,HLA PL Antigens,HLA SB Antigens
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D059868 HLA-DP beta-Chains Transmembrane proteins that form the beta subunits of the HLA-DP antigens. HLA Class II Histocompatibility Antigen, DP beta Chains,HLA DP beta Chains,beta-Chains, HLA-DP
D018628 Gene Dosage The number of copies of a given gene present in the cell of an organism. An increase in gene dosage (by GENE DUPLICATION for example) can result in higher levels of gene product formation. GENE DOSAGE COMPENSATION mechanisms result in adjustments to the level GENE EXPRESSION when there are changes or differences in gene dosage. Gene Copy Number,Copy Number, Gene,Copy Numbers, Gene,Dosage, Gene,Dosages, Gene,Gene Copy Numbers,Gene Dosages,Number, Gene Copy,Numbers, Gene Copy
D020022 Genetic Predisposition to Disease A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. Genetic Predisposition,Genetic Susceptibility,Predisposition, Genetic,Susceptibility, Genetic,Genetic Predispositions,Genetic Susceptibilities,Predispositions, Genetic,Susceptibilities, Genetic
D020641 Polymorphism, Single Nucleotide A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. SNPs,Single Nucleotide Polymorphism,Nucleotide Polymorphism, Single,Nucleotide Polymorphisms, Single,Polymorphisms, Single Nucleotide,Single Nucleotide Polymorphisms

Related Publications

Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
Polymorphism in the third intron of the interferonγ gene is associated with susceptibility to multiple sclerosis.
February 2017, Genetics and molecular research : GMR,
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
HLA-DPB1*0201 is associated with susceptibility to atopic myelitis in Japanese.
October 2012, Journal of neuroimmunology,
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
HLA-DPB1 gene polymorphism and multiple sclerosis: a large case-control study in the southwest of France.
November 1991, Journal of neuroimmunology,
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
HLA-dPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301.
February 2006, Multiple sclerosis (Houndmills, Basingstoke, England),
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population.
December 2009, Psychiatry research,
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
No association between susceptibility to multiple sclerosis and HLA-DPB1 alleles in the French Canadian population.
April 1991, Tissue antigens,
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ?
October 1991, Human immunology,
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
Is tumor necrosis factor-376A promoter polymorphism associated with susceptibility to multiple sclerosis?
January 2007, Medicina,
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations.
December 2009, Multiple sclerosis (Houndmills, Basingstoke, England),
Judith Field, and Sharon R Browning, and Laura J Johnson, and Patrick Danoy, and Michael D Varney, and Brian D Tait, and Kaushal S Gandhi, and Jac C Charlesworth, and Robert N Heard, and , and Graeme J Stewart, and Trevor J Kilpatrick, and Simon J Foote, and Melanie Bahlo, and Helmut Butzkueven, and James Wiley, and David R Booth, and Bruce V Taylor, and Matthew A Brown, and Justin P Rubio, and Jim Stankovich
CTLA4 is associated with susceptibility to multiple sclerosis.
January 2003, Journal of neuroimmunology,
Copied contents to your clipboard!